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Abstract: The interactions of human and bovine serum albumins (HSA and BSA) with various drugs using spectroscopic 
techniques have received great attention now a days due to their significant effect in the biomedical field. UV absorption and 
fluorescence spectroscopy are the most likable due to its high sensitivity and simplicity. The interaction of HSA and BSA with 
vitamin C was investigated. Results showed that the absorption and fluorescence intensities increased as the vitamin C 
concentration increases. The calculated binding constant (k ~10
4
 M
-1
) showed a week binding of vitamin C with both serum 
albumins. The analysis of fluorescence quenching for HSA/BSA-vitamin C interaction (kq ~ 10
11
 L mol
-1
 s
-1
) reveals the 
dynamic quenching process and clearly confirms the existence of static mechanism of fluorescence quenching.  
Keywords: Vitamin C, Human Serum Albumin, Bovine Serum Albumin, UV-Absorption, Fluorescence Spectroscopy, 
Binding Constant, Binding Mode 
 
1. Introduction 
Protein is an important chemical substance in our life and 
one of the main targets of all medicines in organism. Serum 
albumins, especially bovine (BSA) and human (HSA), 
labeled with fluorescent probes are commonly used for the 
investigation of surface induced conformational changes in 
protein interfaces [1-3]. From a biopharmaceutical point of 
view, one of the most important biological functions of 
albumins is their ability to carry drugs, endogenous and 
exogenous substances [4]. Both BSA and HSA have very 
high conformational adaptability to a great variety of ligands 
[5]. Some groups have studied the in vivo consequences of 
binding of drugs and other metabolites to serum albumins [6-
8]. Others have examined the binding mechanism using 
absorption, fluorescence, circular dichroism etc [9-12]. Based 
on such studies, information on the binding process of many 
exogenous ligands like long chain fatty acids, amino acids, 
metals, drugs etc have been reported at the molecular level 
[13]. HSA and BSA, two of the most extensively studied 
serum albumins. However, there are still some differences 
between them [14]. HSA contains a single tryptophan (Trp-
214) [15], while BSA has two tryptophan residues that 
possess intrinsic fluorescence: Trp-212 is located within a 
hydrophobic binding pocket of the protein and Trp-134 is 
located on the surface of the molecule [16]. Therefore, the 
experimental results of the interaction between drugs and 
BSA cannot be completely identical with those of HSA. 
Therefore, study of the interaction between protein and 
drug molecules will help provide basic information on the 
pharmacological actions, bio-transformation, bio-distribution 
of drugs [17]. The binding phenomena will also be useful to 
explain the relationship between the structures and functions 
of proteins. There are some popular techniques which have 
been used to investigate the interaction between drugs and 
proteins. UV-absorption and fluorescence spectroscopy are 
of the powerful techniques to study molecular interactions 
which changes local environment of fluorophore and helps to 
predict the binding phenomenon of drugs to proteins [18-21]. 
There are a number of reports in the literature, where binding 
of metabolites, drugs, dyes, fatty acids, bio-active-substances 
have been studied in detail. So the nature of binding of a 
ligand with HSA (BSA) is different for different ligands [22 - 
25]. 
Vitamin C or L-ascorbic acid, is an essential nutrient for 
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humans and certain other animal species. Vitamin C refers to 
a number of vitamins that have vitamin C activity in animals, 
including ascorbic acid and its salts, and some oxidized 
forms of the molecule like dehydroascorbic acid [26]. 
Vitamin C is a cofactor in at least eight enzymatic reactions, 
including several collagen synthesis reactions that, when 
dysfunctional, cause the most severe symptoms of scurvy 
[27]. In animals, these reactions are especially important in 
wound-healing and in preventing bleeding from capillaries 
[28]. Ascorbate may also act as an antioxidant against 
oxidative stress. Designated chemically as 2-Oxo-L-threo-
hexono-1,4-lactone-2,3-enediol. The molecular weight is 
176.12 g/mol. Its molecular formula is C6H8O6
 
[29]
.
 The 
structural formula is given in Figure 1: 
 
Figure 1. The structure of L-ascorbic acid. 
In this work, this paper mainly studied about the 
interaction of human and bovine serum albumins with 
vitamin C using UV-absorption and fluorescence 
spectroscopic techniques, and to do a comparison between 
the binding behaviors of both proteins with vitamin C.  
2. Experimental 
2.1. Chemicals 
HSA and BSA (purity > 99%) was purchased from Sigma 
Aldrich Company, and vitamin C was purchased from Al-
Quds Co. pharmaceutical chemical industries, their solutions 
were prepared in phosphate buffer solutions (pH=7.4). The 
other substances are of reagent grade, and were used without 
further purifications. 
A final concentration of (40 mg/ml) of HSA and BSA was 
used in the final vitamin C-protein solution, then the solution 
was placed in ultrasonic water path (SIBATA AU-3T) for one 
hour to ensure that all the amount of vitamin C was 
completely dissolved. The final concentrations of Vitamin C-
Protein complexes were prepared by mixing equal volumes 
of HSA and BSA to equal volume from different 
concentration of vitamins C. HSA and BSA concentrations in 
all samples kept at 40mg.ml
-1
. The final concentrations of the 
vitamin C are (40, 20, 10, 5, 2 and 1mg.ml
-1
). The solution 
were incubated for 1 h (at 25°C) before spectroscopic 
measurements were taken. 
2.2. Apparatus 
UV-VIS spectrophotometer 
The absorption spectra were obtained by the use of a 
NanoDrop ND-1000 spectrophotometer. It is used to 
measure the absorption spectrum of the samples in the 
range between 220-750 nm, with high accuracy and 
reproducibility. 
Fluorescence spectrometer 
The fluorescence measurements were performed by a 
NanoDrop ND-3300 Fluoro-spectrophotometer at 25°C. The 
excitation source comes from one of three solid-state light 
emitting diodes (LEDs). The excitation source options 
include: UV LED with maximum excitation 365 nm, Blue 
LED with excitation 470 nm, and white LED from 500 to 
650nm excitation. A 2048-element CCD array detector 
covering 400-750nm, is connected by an optical fiber to the 
optical measurement surface. The excitation is done at the 
wavelength of 360 nm and the maximum emission 
wavelength is at 439 nm. 
The absorption and emission spectra were recorded for 
free HSA and BSA at 40mg.ml
-1
 and for its complexes with 
vitamin C solution with the concentrations of (40, 20, 10, 5, 2 
and 1mg.ml
-1
). Repeated measurements were done for all 
samples. 
3. Results and Discussions 
3.1. UV Absorption Spectra 
UV–vis absorption measurement is a simple and 
pertinent method that is used to investigate structural 
changes and to explore complex formation [30]. To 
initially verify the quenching mechanism, the UV 
absorption spectra of HSA-vitamin C and BSA-vitamin C 
were measured and recorded. As shown in Figure 2, both 
proteins showed an absorption peak of 268 nm. With the 
addition of vitamin C, the intensity increased, indicating 
disturbances to the microenvironment around the amide 
bonds in the protein. The results demonstrated the 
existence of an interaction between HSA and BSA with 
vitamin C, this is due to major ligand protein interaction at 
protein surface which does not limit the mobility of ligand 
around protein molecule. 
 
(a) 
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(b) 
Figure 2. UV-absorbance spectra of different concentrations of vitamin C 
(a=free HSA, b=1mg.ml-1, c=2mg.ml-1, d=5mg.ml-1, e=10mg.ml-1, 
f=20mg.ml-1, g=40 mg.ml-1) with a. HSA, b. BSA. 
The absorption data were treated using linear reciprocal 
plots based on the following equation [31]. 
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where A0 corresponds to the initial absorption of protein at 280 
nm in the absence of ligand, A∞ is the final absorption of the 
ligated protein, and A is the recorded absorption at different 
vitamin C concentrations (L). Figure 3 represents the double 
reciprocal plots of 1/(A- A0) vs. 1/L for HSA-vitamin C and 
BSA-vitamin C complexes. The binding constant (K) can be 
estimated from the ratio of the intercept to the slope. The 
obtained values of the binding constants indicates a relatively 
weak interaction of vitamin C with HSA (K=1.28 x 10
4
 M
-1
) 
and with BSA (K= 1.39x10
4
 M
-1
) when compared to other 
drug-protein complexes with binding constants in the range of 
10
5
 and 10
6
 M
-1
 [32-34]. The reason for the low stability can 
be attributed to the presence of mainly hydrogen-bonding 
interaction or an indirect Protein-vitamin interaction through 
water molecules [25]. 
 
Figure 3. The plot of 1/(A-Ao) vs. 1/L for HSA and BSA with different 
concentrations of vitamin C. 
3.2. Fluorescence Quenching 
Fluorescence quenching studies to explore the binding 
interaction of drug ligands with proteins is considered as the 
best methodology [35]. This quenching resulted from the 
reduction of quantum yield of fluorescence from a 
fluorophore induced by a variety of molecular interaction 
with a quencher molecule [36, 37]. An Increase in the 
concentration of quencher will mask the fluorophore, result 
in reduction of emitted fluorescence from the fluorophore 
molecules. In ease of targeting specific location regarding the 
binding pattern of protein, we used different wavelength. 
Generally, the fluorescence of HSA and BSA comes from 
tryptophan, tyrosine and phenylalanine residues. During data 
recording at an excitation wavelength at 280 nm, 
fluorescence of albumin was coming from both tryptophan 
and tyrosine residues, whereas 293 nm wavelength excited 
tryptophan residues only [38]. 
 
(a) 
 
(b) 
Figure 4. Fluorescence emission spectra in the absence and presence of 
vitamin C (a=free (HSA (a), BSA (b), b=1mg.ml-1, c=2mg.ml-1, d=5mg.ml-1, 
e=10mg.ml-1, f=20mg.ml-1, g=40mg.ml-1). 
Figure 4 represents the fluorescence spectra of HSA and 
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BSA in combination with different concentrations of vitamin 
C. It was observed that fluorescence spectrum exhibiting the 
peak maximum at 460 nm for HSA-vitamin C complexes 
(Figure 4a) while the peak maximum appears to be at 440 nm 
for BSA-vitamin C complexes (Figure 4b). The fluorescence 
intensity decreases with increasing concentrations of vitamin 
C. This indicated that there was some alteration in the 
microenvironment of the fluorophore Trp-213 upon 
interaction of both proteins with vitamin C. 
Fluorescence quenching is usually classified into two 
types: dynamic quenching and static quenching. It can be 
distinguished by their different dependence on temperature 
and excited-state lifetime [39, 40]. For the dynamic 
quenching, higher temperatures will result in faster diffusion 
and larger amounts of collisional quenching. Therefore the 
quenching constant values will go up with the increase in 
temperature, but the reversed effect will be observed for 
static quenching [41]. To analyze the fluorescence quenching 
mechanism, the Stern–Volmer equation [42] was used: 


 1  	
  1  	
                (2) 
where F0 and F are protein (HSA and BSA) fluorescence 
intensities in the absence and presence of quencher (Vitamins 
C); kq is the protein bimolecular quenching rate constant;  is 
the average fluorescence lifetime of protein molecule without 
quencher (of the order of 10
-8
 [43]); [L] is the concentration of 
quencher, ksv is Stern-Volmer fluorescence quenching constant. 
As presented in Figure 5, the Stern-Volmer plot of both 
complexes fluorescence intensities. The two plots showed 
good linear relationship, suggesting the existence of a single 
type of quenching (dynamic or static) and/or a single binding 
site. The values of the fluorescence quenching constant 
determined applying Eq. (2) are equal to (9.46 × 10
3
, 4.78 × 
10
3
) L mol
-1
 for HSA/BSA-vitamin C respectively, both 
values are much lower than other ksv values for the similar 
systems signalized earlier in literature [9, 44]. The values of 
kq which are equal to (9.46 × 10
11
, 4.78 × 10
11
) L mol
-1
 s
-1
 for 
HSA/BSA-vitamin C respectively. These values confirms 
clearly the existence of static (diffusion- independent) 
mechanism of fluorescence quenching [8, 17, 45]. 
 
Figure 5. The Stern-Volmer plot for HSA/BSA- vitamin C complexes. 
The calculated values of kq were greater than of the 
maximum dynamic quenching constant for various quencher 
with biopolymer (2x10
10
 L.mol
-1
.s
-1
) [46], this suggested that 
the fluorescence quenching was not the result of dynamic 
quenching, but the consequence of static quenching [47]. 
When static quenching is dominant, the modified Stern- 
Volmer equation could be used [48]. 
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where K is the binding constant, a plot of 


vs


 is 
presented in Figure 6. The two plots are linear and have a 
slope of 

	
 and intercept 


 according to eq. (3). The values 
of K were found to be (1.3× 10
4 
M
-1
, 1.6 × 10
4
 M
-1
) for 
HSA/BSA-vitamin C respectively, which agrees well with 
the values obtained earlier by UV spectroscopy and supports 
the effective role of static quenching. 
 
Figure 6. The plot of 1/(F0-F) vs. 1/L× 10
5 for HSA/BSA-Vitamin C 
complexes. 
4. Conclusions 
One of the crucial steps in developing a new and effective 
drug is studying and understanding its ability to bind to 
albumins, as serum albumin play a key role in the transport, 
distribution, metabolism and excretion of drugs molecules. In 
this work, the interaction between HSA/BSA-vitamin C was 
investigated by fluorescence and UV spectroscopic 
techniques. The results showed that the fluorescence of HSA 
and BSA would be quenched with the addition of vitamin C. 
This change was via static quenching. The calculated binding 
constants of the interaction of vitamin C with both proteins 
using both techniques showed a good agreement but the 
values were found to be relatively week. 
The conclusions are important in the field of 
pharmacology and biochemistry and are helpful for 
understanding the effect of vitamin C on protein function 
during the blood transportation process. The clear and 
quantitative information on the nature of this study may 
provide some information for its rational use in clinical 
practice. 
 European Journal of Biophysics 2018; 6(1): 17-22 21 
 
Acknowledgements 
This work is supported by the German Research 
Foundation DFG grant no. DR228/242 
 
References 
[1] Xiangrong Li, ab Gongke Wang, a Dejun Chena and Yan Lu, 
Binding of ascorbic acid and α-tocopherol to bovine serum 
albumin: a comparative study. Molecular biosystem. 2014,10: 
326-330. 
[2] Guo X-J, Sun X-D, Xu S-K. Spectroscopic investigation of 
the interaction between riboflavin and bovine serum albumin. 
Journal of Molecular Structure. 2009, 931:55–9. 
[3] Magdalena Makarska-Bialokoz, Investigation of the binding 
affinity in vitamin B12—Bovine serum albumin system using 
various spectroscopic methods, Spectrochimica Acta Part A: 
Molecular and Biomolecular Spectroscopy. 2017, 155 262–
269. 
[4] Houaria Merine, Lahcene Tennouga, Abderrezzak Mesli, Nafa 
Chafi, Kouider Medjahed, Kinetic Study of the Controlled 
Release of Procaine Grafted in Monomer and Copolymer 
Supports in both Homogeneous and Heterogeneous Medium, 
American Journal of Polymer Science. 2013, 3 (6): 99-106. 
[5] Analytical profiles of drug substances and excipients, volume 
26, 1990, Academic press, New Jersey, ISBN:0-12-260826-7. 
[6] Adriana Fuliaş, Ionuţ Ledeţi, Gabriela Vlase, Călin Popoiu3, 
Alina Hegheş, Mihai Bilanin, Titus Vlase, Dorina 
Gheorgheosu, Marius Craina, Simona Ardelean, Dumitru 
Ferechide, Otilia Mărginean and Liana Moş, Thermal 
behaviour of procaine and benzocaine Part II: compatibility 
study with some pharmaceutical excipients used in solid 
dosage forms, Chemistry Central Journal. 2013, 7:140. 
[7] Saqer Darwish, Sawsan E Abu sharkh, Mahmoud M M Abu-
hadid, Musa M Abu Teir, Sami A Makharza,, Spectroscopic 
study of propofol binding to human serum albumin, 
Biophysical Reviews and Letters. 2010, 5: 209–226. 
[8] S. Nafisi, G. Sadeghi, A. Panahyab, Interaction of aspirin and 
vitamin C with bovine serum albumin, Journal of 
Photochemistry and Photobiology B: Biology. 2011, 105: 
198–202. 
[9] B. P. Kamat and J. seetharamappa, Spectroscopic Studies on 
the Mechanism of Interaction of Vitamin B12 with Bovine 
serum albumin, Journal of Photoscience. 2004, 11 (1): 29-33. 
[10] H. Xu, Q. Leu, Spectroscopic Studies on the Interaction of 
Vitamin C with Bovine Serum Albumin, J Solution Chem. 
2009, 38: 15–25. 
[11] Tushar, K. M., Kalyan, S. G., Anirban, S., Swagata, D., The 
interaction of silibinin with human serum albumin:A 
spectroscopic investigation. Journal of Photochemistry and 
Photobiology A: Chemistry. 2008, 194: 297–307. 
[12] Uversky, V., and Permykov, A., (2007): Methods in Protein 
Structure and Stability Analysis; Vibrational spectroscopy, 
Nova Science Publishers, Inc, Hauppauge, New York. 
[13] Sirotkin, V. A., Zinatullin, A. N., Solomonov, B. N., Faizullin, 
D. A. and Fedotov, V. D., "Calorimetric and Fourier transform 
Infrared Spectroscopic Study of Solid Proteins Immersed in 
Low Water Organic Solvents," Biochimica et Biophysica 
Acta, 2001, 1547: 359-369. 
[14] Y. N. Chirgadze, O. V. Fedorov, N. P. Trushina," Secondary 
structure of Na+, K+-dependent adenosine triphosphatase," 
Biopolymers. 1975, 14: 679-694. 
[15] Barth, A. (2000). The infrared absorption of amino acid side 
chains. Progress in Biophysics & Molecular Biology. P:141-
173. 
[16] Buxbaum, E. (2007). Fundamentals of protein structure and 
function, Springer Science & Business media, LLC. 
[17] Zhang, Guowen; Que, Qingmin; Pan, Junhui; Guo, Jinbao, 
Study of the interaction between icariin and human serum 
albumin by fluorescence spectroscopy,, Journal of Molecular 
Structure. 2008, 881: 132–138. 
[18] Li-Xia Xie, Hai-Long Wu, Chao Kang, Shou-Xia Xiang, 
Xiao-Li Yin, Hui-Wen Gu, Qi Zuo and Ru-Qin Yu, 
Quantitative Investigation of the Dynamic Interaction of 
Human Serum Albumin with Procaine Using a Multi-
wayCalibration, Annal. Methods. 2015, 7: 6552. 
[19] S. Shahrakia,, F. Shiria and H. Mansouri-Torshizib 
Biophysical and Molecular Docking Studies of Human Serum 
Albumin Interactions with a Potential Anticancer Complex, 
Biomacromol. J. 2016, 2: 65-77. 
[20] Samira Ranjbar, Yalda Shokoohinia, Sirous Ghobadi, 
NooshinBijari, Saeed Gholamzadeh, Nastaran Moradi, 
Mohammad Reza Ashrafi-Kooshk, Abbas Aghaei, and Reza 
Khodarahmi, Studies of the Interaction between 
Isoimperatorin and Human Serum Albumin by Multi 
spectroscopic Method: Identification of Possible Binding Site 
of the Compound Using Esterase Activity of the Protein, The 
Scientific World Journal 2013, 1-13. 
[21] Nanda RK, Sarkar N, Banerjee R. Probing the interaction of 
ellagic acid with human serum albumin: a fluorescence 
spectroscopic study. J Photochem Photobiol A Chem. 2007, 
192:152–158. 
[22] Colin, D. (2014). Introduction to Protein Structure Prediction. 
www.biostst.wisc.edu/bmi776/ 
[23] Cui Y, Wei Q, Park H Kl. Nanowire nanosensors for highly 
sensitive and selective detection of biological and chemical 
species. Science. 2001, 293: 1289–1292. 
[24] Surewicz W K, Mantsch H H, Chapman D. Determination of 
protein secondary structure by Fourier transform infrared 
spectroscopy: A critical assessment. Biochemistry. 1993, 32: 
389–394. 
[25] Brewer S H, Glomm W R, Johnson M C. Probing BSA 
binding to citrate-coated gold nanoparticles and surfaces. 
Langmuir, 2005, 21: 9303–9307. 
[26] Gao D J, Tian Y, Bi S Y. Studies on the interaction of colloidal 
gold and serum albumins by spectral methods. Spectrochim 
Acta Part A, 2005, 62: 1203–1208. 
[27] Ojha B, Das G. The interaction of 5-(alkoxy) naphthalen-1-
amine with bovine serum albumin and its effect on the 
conformation of protein. J Phys Chem B, 2010, 114: 3979–
3986. 
[28] Bourassa P, Kanakis C D, Tarantilis P, et al. Resveratrol, 
genistein, and curcumin bind bovine serum albumin. J Phys 
Chem B, 2010, 114: 3348–3354. 
22 Husain Alsamamra et al.:  Comparative Studies on the Interaction of Human and Bovine Serum Albumins with Vitamin C  
 
[29] Sawaki, K., and Kawaguchim, M. "Some Correlations 
between procaine-induced convulsions and monoamides in the 
spinal cord of rats". Japanese Journal of Pharmacology. 1989, 
51: 369-376. 
[30] Tayyebeh Madrakian, Habibollah Bagheri, Abbas Afkhami, 
Mohammad Soleimani, Spectroscopic and molecular docking 
techniques study of the interaction between oxymetholone and 
human serum albumin, J lumen. 2014, 155 218-225. 
[31] Carter, D. C.; He, X.-M.; Munson, S. H.; Twigg, P. D.; 
Gernert, K. M.; Broom, M. B.; Miller, T. Y. Three-
dimensional Structure of Human Serum Albumin. Science 
1994, 244: 1195-1198. 
[32] Ahlbom A. A pooled analysis of magnetic fields and 
childhood leukaemia. Br. J. Cancer. 2000, 83: 692–698. 
[33] International Agency for Research on Cancer 2002. Static and 
extremely low-frequency (ELF) electric and magnetic fields. 
IARC monographs on the evaluation of carcinogenic risks to 
humans, vol. 80 Lyon, France: IARC. 
[34] National Radiological Protection Board (2001). ELF 
electromagnetic fields and the risk of cancer. Report of an 
Advisory Group on Non-ionising Radiation. Documents of the 
NRPB, vol 12 Chilton, Oxon, UK: NRPB. 
[35] Lin, H., Lan, J., Guan, M., Sheng, F., Zhang, H. Spectroscopic 
investigation of interaction between mangiferin and bovine 
serum albumin, Spectrochimica Acta A, 2009, 73: 936–941. 
[36] Connors, K. A., Binding Constants: the Measurement of 
Molecular Complex Stability, John Wiley & Sons, New York, 
1987. 
[37] Bai, S., Jain, M. K., Berg, O. G. Contiguous binding of 
decylsulfate on the interface binding surface of pancreatic 
phospholipase A2, Biochemistry. 2008, 47: 2899–2907. 
[38] Liedvogel M, Mouritsen H. Cryptochromes: a potential 
magnetoreceptor: what do we know and what do we want to 
know? J. R. Soc. Interface. 2010, 7: S147–S162. 
[39] Byler, D. M., Susi, H. Examination of the secondary structure 
of proteins by deconvolved FTIR spectra, Biopolymers. 1986, 
25: 469–487. 
[40] Dockal, M., Chang, M., Carter, D. C., Rüker, F. Five 
recombinant fragments of human serum albumin-tools for the 
characterization of the warfarin binding site, Protein Science. 
2000, 9: 1455–1465. 
[41] Ahmed, A., Tajmir-Riahi, H. A., Carpentier, R. A quantitative 
secondary structure analysis of the 33 kDa extrinsic 
polypeptide of photosystem II by FTIR spectroscopy, FEBS 
Letters. 1995, 363: 65–68. 
[42] Ritz T, Adem S, Schulten K., “A model for 
photoreceptorbased magnetoreception in birds,” Biophys. J. 
2000, 78: 707– 718. 
[43] Shubhajit Paul, Alexey S. Kiryutin, Jinping Guo, Konstantin 
L. Ivanov, Jorg Matysik, Alexandra V. Yurkovskaya & Xiaojie 
Wang, Magnetic field effect in natural cryptochrome explored 
with model compound, Scientific Reports. 2017, 7: 11892. 
[44] Lakowicz, J. (2006): Principles of Fluorescence Spectroscopy, 
3rd ed, Springer Science+Business Media, USA. 
[45] Lakowicz, J. R. (2002). Topics in fluorescence spectroscopy, 
Vol 5, Kluwer academic publishers. 
[46] Brescoll, J., Daveluy, S., A Review Of Vitamin B12 In 
Dermatology. Annal Hematology. 2015, 16: 27-33. 
[47] Sudlow, G., Birkett, D. J., Wade, D. N. Further 
characterization of specific drugbinding sites on human serum 
albumin, Molecular Pharmacology. 1976, 12: 1052–1061. 
[48] Frei, B., England, L., Ames, B. N. Ascorbate is an outstanding 
antioxidant inhuman blood plasma, Proceeding of National 
Academy of Sciences. 1989, 86: 6377–6381. 
[49] Krimm, S., Bandekar, J. Vibrational spectroscopy and 
conformation of peptides, polypeptides, and proteins, 
Advances in Protein Chemistry. 1986, 38: 181–364. 
[50] Connors, K. A., Binding Constants: the Measurement of 
Molecular Complex Stability, John Wiley & Sons, New York, 
1987. 
[51] Bai, S., Jain, M. K., Berg, O. G. Contiguous binding of 
decylsulfate on the interface binding surface of pancreatic 
phospholipase A2, Biochemistry. 2008, 47: 2899–2907. 
[52] Bhattacharya, A. A., Curry, S., Franks, N. P. Binding of the 
general anesthetics propofol and halothane to human serum 
albumin, Journal of Biological Chemistry. 2000, 275: 38731–
38738. 
 
 
